Bijun Shi

Bijun Shi

Auto-generated profile, based on publicly available information

Bijun Shi

Sun Yat-sen University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2018 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
WWWeijia Wu
Weijia Wu
LLLizi Lin
Lizi Lin
BSBijun Shi
Bijun Shi
JJJin Jing
Jin Jing
Li CaiLi Cai
Li Cai
Early life nutritional exposures could modify the gene expression and susceptibility of allergic diseases (AD). This systematic review aimed to evaluate whether early life (the first 1,000 days) natural exposure to polyunsaturated fatty acids (PUFA) and ruminant trans fatty acids (R-TFA) could affect the AD risk. We searched PubMed, EMBASE, PsycINFO, Scopus, the Cochrane Library, and ClinicalTrials.gov from inception through September 10, 2017 for relevant full-text articles in English. Observational studies were selected if they examined the effects of early life PUFA or R-TFA on AD (eczema, asthma, wheeze, and allergic rhinitis) or sensitization. The quality of studies was examined by the Newcastle-Ottawa Scale, and the best evidence synthesis (BES) was applied. We included 26 observational studies, and 8 of them showed high quality. BES showed a moderate evidence for the protective effect of vaccenic acid (VA, an R-TFA) on eczema, while insufficient or no evidence was found in other associations. Meta-analysis showed that higher n-6/n-3 ratio and linoleic acid were associated with higher risk of eczema (pooled odds ratio [OR] = 1.06, 95% confidence intervals [CI]: 1.00 −1.13; 1.08, 95% CI: 1.01 −1.15). However, VA was inversely associated with eczema pooled OR = 0.42, 95% CI: 0.25 −0.72). Early life natural exposure to VA showed evident benefit on decreasing the risk of eczema, while PUFA and other R-TFA showed limited effects on AD. More robust studies especially for R-TFA are required.

2 December 2022 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
LLLili Lin
Lili Lin
GLGuosheng Liu
Guosheng Liu
YLYing Li
Ying Li
BSBijun Shi
Bijun Shi
ZSZhiwen Su
Zhiwen Su
FWFan Wu
Fan Wu
Low Apgar score is associated with increased risk of death in preterm or full-term infants. However, the use of Apgar score to assess extremely preterm (EP) infants is controversial. In this study, we characterized the distribution of Apgar scores in EP infants with gestational age between 25 and 27 weeks, and investigated the association of Apgar score with survival rate at discharge by analyzing the clinical data of the EP infants discharged between January 2008 and December 2017 from 26 neonatal intensive care units in Guangdong Province, China. A total of 1567 infants with gestational age of 26.84±0.79 weeks and birth weight of 951±169 grams were involved in our study. The Apgar score increased with gestational age from 25 to 27 weeks and with time from birth from 1 to 10 min. The survival rate increased with a higher Apgar score, but no significant difference was found for 1-min Apgar score and the survival rate between infants with 25 or 26 weeks of gestation or 5-min Apgar score in infants with 25 weeks of gestation. The Apgar score is associated with survival of EP infants.

11 March 2020 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
Li CaiLi Cai
Li Cai
WWWeijia Wu
Weijia Wu
LLLizi Lin
Lizi Lin
YCYajun Chen
Yajun Chen
RGRui Gao
Rui Gao
JJJin Jing
Jin Jing
Aims/Introduction: The role of irisin in maternal glucose metabolism and how it would respond to dietary n‐3 polyunsaturated fatty acid (n‐3 PUFA) intake remains unclear. This study aimed to explore whether maternal plasma irisin is associated with glucose metabolism and whether this association is modified by dietary n‐3 PUFA.Materials and Methods: A total of 932 pregnant women (20–28 weeks’ gestation) aged 20–45 years were recruited. Dietary n‐3 PUFA was estimated using a validated quantitative food frequency questionnaire. Plasma irisin and insulin were tested by enzyme‐linked immunosorbent assay, and insulin resistance (IR) was estimated using the homeostatic model assessment (HOMA). Gestational diabetes mellitus was diagnosed with a 75‐g oral glucose tolerance test. Adjusted multivariable linear regression and logistic regression were carried out to examine the associations between plasma irisin and glucose metabolism. The moderating effect of dietary n‐3 PUFA intake was determined by fully multiplicative models by including the interaction term.Results: Maternal plasma irisin was negatively associated with HOMA‐IR and oral glucose tolerance test 0 h glucose level (β −0.250, −0.067; correctedP‐value for false discovery rate = 0.012, 0.018, respectively), positively associated with HOMA of insulin sensitivity (β 0.028; correctedP‐value for false discovery rate = 0.012), but not associated with postprandial glucose or the risk of gestational diabetes mellitus. Furthermore, we found a moderating effect of dietary n‐3 PUFA on the relationships of plasma irisin with HOMA‐IR and HOMA of insulin sensitivity; these associations were strengthened with increased n‐3 PUFA intake (β −0.037, 0.004;P = 0.014, 0.041, respectively).Conclusions: Plasma irisin was negatively associated with HOMA‐IR and fasting glucose, whereas it was positively associated with HOMA of insulin sensitivity in pregnant women. We first showed that these associations were modified by dietary n‐3 PUFA intake.

26 February 2020 in Research Square
Verified
Preprint
Open access
PDF file
BSBijun Shi
Bijun Shi
WWWeijia Wu
Weijia Wu
MDMeixia Dai
Meixia Dai
JZJingjing Zeng
Jingjing Zeng
JLJingyin Luo
Jingyin Luo
JJJin Jing
Jin Jing
Background Early comprehensive treatment models (CTMs) have developed as effective treatments for children with autism spectrum disorder (ASD). Numerous studies have suggested that they can improve short-term outcomes, but little is known about middle childhood outcomes. The current meta-analysis reviewed studies reporting broader outcomes in middle childhood in children with ASD who ever participated in a CTM and examined the predictors of primary outcomes. Methods We searched eight databases up to June 13, 2019, for relevant trials and natural experiments. Longitudinal studies were selected if they investigated the outcomes of CTMs in middle childhood in children with ASD. Two meta-analyses were undertaken to determine a summary estimate of change in treatment outcomes and evaluate the effect of CTMs; one used the standardized mean change between the pretest and posttest, and the other a classical meta-analysis. Stratified and random effects meta-regression analyses were performed to search for outcome differences among studies. Results Eighteen intervention studies (involving 495 children with ASD) met all the inclusion criteria: 12 used early intensive behavioral intervention (EIBI) and two the Early Start Denver Model (ESDM). Outcomes were categorized into three parts: cognitive, language and behavioral (e.g., adaptive functioning and symptomatology). Overall, most children with ASD in middle childhood who participated in an early CTM make gains in many areas of functioning, especially with regard to symptom and language-related outcomes. Stratified analyses indicated that the ESDM displayed the largest effect on IQ improvement (ES=1.37, 95% CI: 0.95-1.80), while EIBI was more effective for symptom reduction (ES=-1.27, 95% CI: -1.96 to -0.58). Further meta-regression suggested that interventions with parent involvement and longer treatment hours yielded greater improvements in IQ and social adaptive functioning, respectively. Conclusion The results demonstrate a positive association between CTMs and better prognosis in middle childhood, especially regarding symptoms and language. However, most of the extant research involves small, non-randomized studies, preventing definitive conclusions from being drawn. What is certain is that the outcomes in middle childhood of children with ASD are still far from normal, especially for adaptive functioning, and the three mediating variables were treatment elements: approach, implementer and total treatment hours.

9 June 2020 in Research Square
Verified
Preprint
Open access
PDF file
BSBijun Shi
Bijun Shi
WWWeijia Wu
Weijia Wu
MDMeixia Dai
Meixia Dai
JZJingjing Zeng
Jingjing Zeng
JLJingyin Luo
Jingyin Luo
JJJin Jing
Jin Jing
Background Early comprehensive treatment models (CTMs) have been developed as effective treatments for children with autism spectrum disorder (ASD). Numerous studies have suggested that CTMs can improve short-term outcomes, but little is known about outcomes in mid-childhood and adolescence. The current meta-analysis reviewed studies reporting broader outcomes in children and adolescents with ASD who had ever participated in a CTM and examined the predictors of developmental gains.Methods We searched eight databases up to June 13, 2019, for relevant trials and natural experiments. Longitudinal studies were selected if they investigated the outcomes of CTMs. Two meta-analyses were undertaken to provide a summary estimate of change in treatment outcomes and to evaluate the effect of CTMs; one used the standardized mean change between the pretest and posttest, and the other was a classical meta-analysis. Stratified and random-effects meta-regression analyses were performed to search for outcome differences among studies. Results Eighteen intervention studies (involving 495 children with ASD) met all the inclusion criteria: 12 used early intensive behavioral intervention (EIBI), and two used the Early Start Denver Model (ESDM). Outcomes were categorized into three parts: cognitive, language and behavioral (e.g., adaptive functioning and symptomatology). Overall, most children with ASD who had ever participated in an early CTM made gains in many areas of functioning, especially in terms of symptom- and language-related outcomes. Stratified analyses indicated that the ESDM displayed the largest effect on IQ improvement (ES=1.37, 95% CI: 0.95-1.80), while EIBI was more effective for symptom reduction (ES=-1.27, 95% CI: -1.96 to -0.58). Further meta-regression suggested that interventions with parent involvement and longer treatment hours yielded greater improvements in IQ and social adaptive functioning, respectively.Conclusion The results demonstrate a positive association between CTMs and better prognosis in mid-childhood and adolescence, especially regarding symptoms and language. However, most extant research involves small, nonrandomized studies, preventing definitive conclusions from being drawn. Clearly, the outcomes of children with ASD are still far from normal, especially with respect to adaptive functioning, and the three mediating variables pertaining to treatment elements can affect their gains, including approach, implementer and total treatment hours.